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The field of preclinical models is a very vast arena, in which finding connections among groups
acting in apparently very distant research areas can sometimes prove challenging. An osmosis of
mindset and competencies (methodologies, techniques, models), along with a comparison of different
standpoints, is always an opportunity to reflect on where one’s work stands in a wider scenario.
The goal of this Special Issue is to collect information, and ultimately share ideas and foster debate
about different approaches to translational model research. The eleven papers composing this issue
will be of interest to researchers looking for an update of the currently heterogeneous panorama of
preclinical models and to those in search of inspiring ideas in the field.
Figure 1 shows a visual representation of the connections among the papers here presented. Each
colored ribbon relates a paper with a topic. It is immediately apparent how many topics are addressed
and how many relationships exist among the different research areas. Multidisciplinarity, which is
intrinsic to the very nature of preclinical models, emerges at first sight as a relevant feature.
Out of eleven papers, six are based on animal models [1–6], highlighting that these models still
play a crucial role in translational medicine, even in a historical moment in which the need to find
alternative methodologies is increasingly pressing.
In this context, the issue raised by some authors about the translational validity of a certain animal
model, in this specific case the Reeler mouse, is very timely. Central to the debate is the rare occurrence
of the very conditions for which mice homozygous for the Reeler mutation have been created, and the
objective difficulty of fully validating the mice expressing the heterozygous genotype as a translational
model for more frequent diseases such as autism and schizophrenia [2].
After all, animal models are often suspended “halfway” between being widely accepted as good
tools for basic research and being recognized for their translational potential. Therefore, this issue
should always be considered when somebody, whether experimenter or modeler, decides to work
with them. In this regard, one paper focuses on the improvement of cellular and animal models of
chondrosarcoma. The authors [4] provide four cell lines, displaying tumorigenic and invasive features
suitable to be used as valuable alternatives to veteran endless passaged cell lines. They also detail the
genetic drift that these cells underwent as an adaptive response to in vitro and in vivo expansion.
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Figure 1. A visual representation of the connections among the papers presented in this Special 
Issue. Several topics were defined by widening the keywords specified in each paper (colored 
sectors on the left side of the image). Papers (gray sectors on the right side of the image) are 
identified by the first author’s name. Colored ribbons connect papers with the topics treated. The 
figure was made with the Circos software [7]. 
Cancer, and more specifically the usage of nanoparticles (NP) both for multimodal imaging 
and as contrast agents (CAs), is the topic of a review [8] which highlights the advantages of using 
NP-based PET/MRI multimodal imaging in tumor diagnosis and characterization. Additionally, 
these nanosystems can be applied to theranostics in the very prominent scenario of personalized 
medicine. The authors point to multidisciplinarity as an essential requisite to deeply understand the 
possible applications and the underlying biomolecular processes of the targeted diseases. 
The centrality of interdisciplinary synergies is further highlighted in a paper [6] specifically 
focused on the high potential held by MRI imaging in translational oncology. By analyzing several 
disease models and cancer types, the authors present their approach to reduce the gap from 
preclinical applications to clinical practice. 
The “from bench to bedside” path is also the leitmotif of an article [9] addressing several issues 
related to the use of human-induced pluripotent stem cells (iPSC). More specifically, the paper 
analyses the potential of iPSC-endothelial cells in accelerating tissue regeneration and their 
suitability to enter progressively more clinical trials. The most represented research field in this 
Special Issue is tissue morphology [1–3,5] followed by tissue engineering [9–11] and neuroscience 
[1–3], with one article intercepting both these areas of expertise [12]. This latter work reports, 
indeed, a method to generate a three-dimensional neuronal system composed of cortical neurons 
and glial cells derived from iPSCs, suitable for drug screening and disease modeling. 
Good news from the field of skin regeneration: the work on bioengineered skin substitutes has 
been selected by the editorial board as the cover story of the issue of December 2019 
(www.mdpi.com/2077-0383/8/12). The article, presented by a group active in the field of dermal 
substitutes [13] and three-dimensional tissue-like models [14], is focused on the analysis of the most 
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Cancer, and more specifically the usage of nanoparticles (NP) both for multimodal imaging
and as contrast agents (CAs), is the topic of a review [8] which highlights the advantages of using
NP-based PET/MRI multimodal imaging in tumor diagnosis and characterization. Additionally, these
nanosystems can be applied to theranostics in the very prominent scenario of personalized medicine.
The authors point to multidisciplinarity as an essential requisite to deeply understand the possible
applications and the underlying biomolecular processes of the targeted diseases.
The centrality of interdisciplinary synergies is further highlighted in a paper [6] specifically
focused on the high potential held by MRI imaging in translational oncology. By analyzing several
disease models and cancer types, the authors present their approach to reduce the gap from preclinical
applications to clinical practice.
The “from bench to bedside” path is also the leitmotif of an article [9] addressing several issues
related to the use of human-induced pluripotent stem cells (iPSC). More specifically, the paper analyses
the potential of iPSC-endothelial cells in accelerating tissue regeneration and their suitability to enter
progressively more clinical trials. The most represented research field in this Special Issue is tissue
morphology [1–3,5] followed by tissue engineering [9–11] and neuroscience [1–3], with one article
intercepting both these areas of expertise [12]. This latter work reports, indeed, a method to generate a
three-dimensional neuronal system composed of cortical neurons and glial cells derived from iPSCs,
suitable for drug screening and disease modeling.
Good news from the field of skin regeneration: the work on bioengineered skin substitutes has
been selected by the editorial board as the cover story of the issue of December 2019 (www.mdpi.com/
2077-0383/8/12). The article, presented by a group active in the field of dermal substitutes [13] and
three-dimensional tissue-like models [14], is focused on the analysis of the most modern strategies to
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overcome the scarring process and promote skin regeneration, by implanting an engineered dermis
capable of recapitulating the architecture and presenting molecular signals similarly to the native
dermis [10].
The essential role of tissue-engineered constructs in mimicking extra-cellular matrix morphology
and function is also highlighted in another work, in which the authors analyze the most promising
fabrication technologies in the field. In particular, the paper reports the real effectiveness of the
“bottom-up” approach for cell-free and cell-laden scaffolds in tissue and organ bioengineering [11].
Passing to the fascinating and complex field of neuroscience, two original research articles
contributed to this Special Issue. It is worth noting how they both witness the increasing value of
the short-lived African turquoise killifish Nothobranchius furzeri as an emerging vertebrate model in
aging research. In particular, one paper describes, for the first time, the expression of neurotrophin-6 in
different brain areas in both young and old animals [1], while the other one provides the first evidence
of nucleobindin-2/nesfatin-1 expression and its role as a food intake regulator in vertebrate aging [3].
Finally, very high translational potential arises from a work proving the effectiveness of human
red blood cells to act as oxygen carriers for graft preservation in liver transplantation. In particular, the
study is aimed at enhancing the potential of normothermic machine perfusion, a modern methodology
applied to organ preservation [15]. In view of the crucial role of transplantation for patients with
end-stage disease and the consequent increasing demand for the inclusion of marginal donors, new
methods to improve organ preservation and, eventually, induce graft repair are undoubtedly relevant
to the clinical setting [5].
An important contribution might come from in silico modeling, a field that has unexpectedly been
neglected in this Special Issue despite being a constitutive piece of the puzzle. In fact, in silico models
prove to be useful at several stages of the process from research to clinical application, in a vision
that aims at a deep digital transformation of all the production steps. This might be accomplished
either with data-driven approaches, such as in omics or materiomics simulations, or with mechanistic
modeling (e.g., bioreactors process) in tissue engineering [16]. Another interesting avenue is the
development of in silico models capable of exploiting patient-specific data to build personalized
medical treatments, such as three-dimensional mathematical models of tumors [17]. The urgency of an
integrated approach merging in vivo experiments and in silico representations to obtain more powerful
descriptive and predictive models is also emerging: for instance, the integration of microfluidic devices
and computational modeling to better study vascularization dynamics in cancer [18].
The harmonization of data coming from different fields [19,20] and the exchange of expertise
at several levels are fundamental parts of an essential strategy whose final aim is to accelerate the
translation and the design of more precise preclinical models, in a true accomplishment of the “from
bench to bedside” paradigm.
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